Home › Funds › Eschler Asset Management LLP › BNTX

Eschler Asset Management LLP position in BNTX

BIONTECH SE · Health Care

Eschler Asset Management LLP reported holding 14,205 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.64% of its reported portfolio and ranking #17 among its reported holdings. Eschler Asset Management LLP has disclosed BNTX holdings in 2 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)14.21K sh
Reported value held$1.40M
Portfolio Weight1.64%
First reportedQ3 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Eschler Asset Management LLP's BNTX position evolved

Eschler Asset Management LLP first disclosed a stake in BNTX in Q3 2025 at 3,580 shares (US$353K). The position peaked in Q3 2026 at 14,205 shares, worth US$1.4M. Across 2 filings, Eschler Asset Management LLP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 14,205 shares valued at US$1.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.58K $353.06K New
Q3 2026 14.21K $1.40M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTX and 13F data

BNTX (BIONTECH SE) is a Health Care company. 28 other funds we track also report a position in BNTX — the largest reported positions include Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTX

All BNTX fund holders →

FAQ

How long has Eschler Asset Management LLP held BNTX?

Eschler Asset Management LLP has disclosed BNTX holdings in 2 of the last 5 reported quarters, going back to Q3 2025.

What is Eschler Asset Management LLP's current position in BNTX?

As of Q3 2026, Eschler Asset Management LLP holds 14.21K shares of BNTX (BIONTECH SE), valued at $1.40M, representing 1.64% of its reported portfolio and ranking #17.

Has Eschler Asset Management LLP been buying or selling BNTX?

In the latest 13F filing (Q3 2026), Eschler Asset Management LLP newly opened its position in BNTX. The position peaked in Q3 2026 at 14.21K shares.

Which other funds hold BNTX?

Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.